Komori
Other Disclosures4593HEALIOS K.K.Pharmaceuticals

Participation in the 10th Chardan's Annual Healthcare Conference

Helios's CFO announced plans to participate in a panel discussion at a healthcare conference to be held in the United States on 20 October 2026. Information was also provided on the live stream and 90-day archive access.

Worth reading
34Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Applicable field (uses covered by this announcement)

Healthcare (ヘルスケア)

Launch date20 October 2026 (scheduled, U.S. time) / Webcast archive available for 90 days
Relationship between the counterparty and the company
HEALIOS K.K.4593
Relationship with the Company

Participation in the conference and appearance on a panel discussion

CounterpartyChardan’s Annual Healthcare Conference / Chardan
Location (as indicated in this announcement)

New York, United States (conference venue)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Chardan website

Announced details
ItemDetails
CounterpartyChardan’s Annual Healthcare Conference / Chardan
Relationship with the CompanyParticipation in the conference and appearance on a panel discussion
Launch date20 October 2026 (scheduled, U.S. time) / Webcast archive available for 90 days
Applicable areaHealthcare (ヘルスケア)
LocationNew York, United States (conference venue)
SourceChardan website
Items this document does not state (12)
Names of Products / Services CoveredCounterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To announce participation in the conference and provide information on the live presentation and archive access.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Participation in the 10th Chardan's Annual Healthcare Conference | HEALIOS K.K. (4593) timely disclosure | Komori